Paul Isaac Holdings Activity

Arbiter Partners Capital Management Portfolio 13F

Arbiter Partners Capital Management has disclosed a total of 11 changes to the portfolio in the latest (2024 Q3) SEC report(s): increased the number of shares of 2, bought 2 totally new, decreased the number of shares of 4 and completely sold out 3 position(s).

What stocks is Paul Isaac buying now?

In the recent quarter Paul Isaac has purchased 4 securities: (GRAL) GRAIL INC (added shares +92.22%), (INBX) INHIBRX BIOSCIENCES INC (new buy), (DESP) DESPEGARCOM CORP (new buy) and (STXS) STEREOTAXIS INC (added shares +0.34%).

What does Paul Isaac invest in?

Paul Isaac's top 5 holdings (by % of portfolio) are (GEF.B) GREIF INC-CL B (27.46%), (SNDA) SONIDA SENIOR LIVING INC (16.88%), (STXS) STEREOTAXIS INC (11.25%), (GRAL) GRAIL INC (7.31%) and (LILAK) LIBERTY LATIN AMERIC-CL C (6.73%).

In the latest report(s) the following changes have been made to the top investments: (SNDA) SONIDA SENIOR LIVING INC (reduced shares -11.73%), (STXS) STEREOTAXIS INC (added shares +0.34%), (GRAL) GRAIL INC (added shares +92.22%) and (LILAK) LIBERTY LATIN AMERIC-CL C (reduced shares -2.71%).

2024 Q3 (11 results)
DESP
buy
+20,000
+0.49%
$12.40
51.21% $18.75
0.49%
INBX
buy
+25,706
+0.87%
$15.66
10.09% $14.08
0.87%
GRAL
+92.22%
+129,108
+3.51%
$13.76
19.99% $16.51
7.31%
STXS
+0.34%
+9,349
+0.04%
$2.04
0.49% $2.05
11.25%
LRFC
-1.38%
-842
-0.04%
$24.83
0.41% $24.93
2.96%
LILAK
-2.71%
-9,000
-0.19%
$9.49
25.82% $7.04
6.73%
LEN.B
-10.38%
-798
-0.27%
$172.94
7.20% $160.49
2.35%
SNDA
-11.73%
-42,646
-2.24%
$26.62
6.72% $24.83
16.88%
LNC
-100.00%
-11,000
-0.68%
$31.10
13.63% $35.34
0.00%
GEG
-100.00%
-255,728
-0.91%
$1.80
1.11% $1.82
0.00%
LH
-100.00%
-8,100
-3.26%
$203.51
17.77% $239.67
0.00%
2024 Q2 (7 results)
GRAL
buy
+140,000
+4.35%
$15.37
7.42% $16.51
4.35%
LH
buy
+8,100
+3.33%
$203.51
17.77% $239.67
0.00%
STXS
+0.94%
+25,505
+0.10%
$1.82
12.64% $2.05
10.24%
SNDA
-25.40%
-123,778
-6.86%
$27.41
9.43% $24.83
20.17%
LNC
-62.71%
-18,500
-1.16%
$31.10
13.63% $35.34
0.00%
GEG
-69.51%
-583,099
-2.12%
$1.80
1.11% $1.82
0.00%
LH
-100.00%
-8,100
-3.58%
$218.46
9.71% $239.67
0.00%
2024 Q1 (14 results)
CRBG
+12.99%
+9,643
+0.53%
$28.73
10.51% $31.75
4.62%
RBKB
+7.99%
+1,000
+0.02%
$8.45
15.38% $9.75
0.21%
LILA
+1.54%
+2,500
+0.03%
$6.97
2.01% $7.11
2.08%
CRESY
+0.98%
+94
+0.00%
$8.93
27.32% $11.37
0.16%
GEG
-1.47%
-11,619
-0.04%
$1.92
5.21% $1.82
2.92%
SNDA
-4.20%
-18,280
-1.10%
$28.50
12.88% $24.83
25.17%
DVN
-9.11%
-1,644
-0.15%
$50.18
21.38% $39.45
1.49%
WRK
-100.00%
-6,372
-0.48%
$41.52
24.06% $51.51
0.00%
FTRE
-100.00%
-4,090
-0.51%
$34.90
43.47% $19.73
0.00%
CWBC
-100.00%
-35,669
-1.12%
$17.39
25.47% $21.82
0.00%
JXN
-100.00%
-69,795
-6.54%
$51.20
98.98% $101.88
0.00%
FG
-100.00%
-10,372
-1.66%
$46.00
5.00% $48.30
0.00%
SPWH
-100.00%
-41,135
-0.32%
$4.26
53.05% $2.00
0.00%
FFNW
-100.00%
-30,000
-0.73%
$13.48
68.47% $22.71
0.00%
2023 Q4 (15 results)
CRESY
buy
+10,000
+0.19%
$9.48
19.94% $11.37
0.19%
STXS
+2.87%
+76,886
+0.27%
$1.75
17.14% $2.05
9.74%
LILA
-0.63%
-1,005
-0.02%
$7.31
2.74% $7.11
2.39%
SNDA
-0.82%
-3,860
-0.11%
$12.50
98.64% $24.83
12.84%
JXN
-3.29%
-2,376
-0.25%
$51.20
98.98% $101.88
0.00%
GEG
-7.65%
-70,503
-0.28%
$1.94
6.19% $1.82
3.33%
SPNT
-19.67%
-21,000
-0.49%
$11.60
34.31% $15.58
2.01%
RBKB
-21.85%
-3,500
-0.06%
$8.05
21.12% $9.75
0.20%
LILAK
-38.39%
-230,000
-3.41%
$7.34
4.09% $7.04
5.47%
LNC
-46.36%
-25,500
-1.39%
$26.97
31.03% $35.34
1.61%
FG
-52.56%
-11,493
-2.05%
$46.00
5.00% $48.30
0.00%
WRK
-83.26%
-31,684
-2.66%
$41.52
24.06% $51.51
0.00%
SPWH
-93.85%
-627,780
-5.40%
$4.26
53.05% $2.00
0.00%
BATL
-100.00%
-17,959
-0.22%
$6.18
43.20% $3.51
0.00%
NWLI
-100.00%
-1,503
-2.12%
$437.49
14.28% $499.98
0.00%
47 of 1,267

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.